Results 181 to 190 of about 530,197 (354)

Parasites in the Etiology of Cancer--Bilharziasis and Bladder Cancer [PDF]

, 1977
I. Elsebai
openalex   +1 more source

Copper‐Based Nanotubes That Enhance Starvation Therapy Through Cuproptosis for Synergistic Cancer Treatment

Advanced Science, EarlyView.
We designed a copper‐based nanotube (NT) with copper ionophores to induce enhanced cuproptosis. In combination with starvation therapy, the NT significantly inhibited energy metabolism in HCC cells. Our results show that the depletion of GSH by Cu2+ intensified oxidative stress and cuproptosis, resulting in ROS generation and DLAT aggregation ...
Xuan Han, Xin Zhang, Zhiping Liu, Hang Liu, Derek Wu, Yinli He, Kexin Yuan, Yi Lyu, Xiaofei Liu   +8 more
wiley   +1 more source

THE CHEMOTHERAPY OF CANCER OF UINARY BLADDER INFLUENCE OF THE CHEMOTHERAPY APPLIED ON CANCER OF URINARY BLADDER INDICATED TOTAL CYSTECTOMY

, 1962
Kenitsu Okita, S. Tasaka, Katsuichi Nanba   +2 more
openalex   +2 more sources

Commentary: Bladder cancer

Current Urology, 2021
Dongqi Tang, Yingzi Qi
openaire   +4 more sources

SF3A3 Drives Tumorigenesis in Endometrial Cancer by Enhancing c‐FOS Expression and Represents a Potential Therapeutic Target

Advanced Science, EarlyView.
The role of splicing factor 3A subunit 3 (SF3A3) in driving endometrial cancer (EC) progression and potential therapeutic interventions. SF3A3, a core component of the U2 small nuclear ribonucleoprotein (U2 snRNP), is upregulated in endometrial cancer (EC) and promotes tumor growth and cisplatin resistance. RNA‐binding protein immunoprecipitation (RIP)
Wei Yu, Yi Gu, Hengrui Zhang, Wunan Huang, Lei Sun, Liangjian Ma, Xiaolei Liang, Lexin Liu, Guiping Chen, Weihua Wang, Zhongkai Cao, Xue Li, Xiangjun Chen, Lidan Hu   +13 more
wiley   +1 more source

Lifetime water arsenic, genetic susceptibility, and bladder cancer in the New England Bladder Cancer Study. [PDF]

JNCI Cancer Spectr
Pomares-Millan H, Koutros S, Baris D, Schwenn M, Johnson A, Rothman N, Silverman DT, Leach SD, Karagas MR, Passarelli MN.   +9 more
europepmc   +1 more source

STUDIES ON THE CHEMOTHERAPY OF CANCER OF URINARY BLADDER HISTOPATHOLOGICAL CHANGES WITH ANTICANCER DRUGS

, 1962
J Oomura, K Ookita, S. Tasaka
openalex   +2 more sources

Immunologic evaluation of human bladder cancer: In vitro studies [PDF]

, 1975
Mostafa Elhilali, Shankar K. Nayak
openalex   +1 more source

Exosomal CMTM4 Induces Immunosuppressive Macrophages to Promote Ovarian Cancer Progression and Attenuate Anti‐PD‐1 Immunotherapy

Advanced Science, EarlyView.
In ovarian tumors with high CMTM4 expression, exosomes transfer CMTM4 to macrophages, upregulating ICAM1 and promoting M2 polarization via p65 nuclear translocation. This suppresses immunity by increasing PD‐1 and Tregs while reducing CD8+ T cells.
Bo Yin, Jianyi Ding, Jie Liu, Haoran Hu, Yashi Zhu, Meiqin Yang, Huijuan Zhou, Baoyou Huang, Tiefeng Huang, Mengjie Li, Yinyan He, Ang Li, Lingfei Han   +12 more
wiley   +1 more source

Statins Are Not Associated with Improved Bladder Cancer Outcomes in Patients with Early-Stage Bladder Cancer Treated with BCG Immunotherapy. [PDF]

Cancers (Basel)
Ndukwe E, Lotan P, Risk M, Koehne EL, Shapiro DD, Tyllo RP, Allen GO, Abel EJ, Jarrard DF, Richards KA.   +9 more
europepmc   +1 more source